Skip to main content
Caplight Logo









Morphoceuticals, Inc.

Morphoceuticals, Inc.

Private
Medford, MassachusettsHealthcare & Life Scienceshttps://www.morphoceuticals.com/

Last Round

Seed

Feb 15, 2023

Total Funding Raised

$8M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Morphoceuticals, Inc. is a biotechnology company that develops AI-guided electroceuticals for tissue repair and organ regeneration by targeting the bioelectrome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

regenerative medicinebioelectric signalingdrug discoveryelectroceuticalstissue regenerationbioelectromesmall-molecule drugsorgan repairAI drug discoverycomputational biologybiotech R&Dbio-hackingregenerative bio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Morphoceuticals, Inc. Comparables

Compare Morphoceuticals, Inc. with similar companies based on industry and business-model similarity.

Morphoceuticals, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mogrify
73%
Turn Biotechnologies
67%
Altos Labs
66%

Morphoceuticals, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 15, 2023

Key People

Founding team and executive leadership

Jim Jenson

CEO, Director

Executive Team

Morphoceuticals, Inc. Investors

Notable investors and investment history

Morphoceuticals, Inc. investors
InvestorRounds
Prime Movers LabSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 69% MoM, from 1.2K to 2.1K.

  • May 14, 2026

    Monthly visitors grew 113% MoM, reaching 2.1K.

Morphoceuticals, Inc. Filings

Explore SEC and related filing metadata, where available.

Morphoceuticals, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Morphoceuticals, Inc.'s valuation, stock price, and market status.

Is Morphoceuticals, Inc. a public or private company?

Morphoceuticals, Inc. is a private company.

What is the current stock price of Morphoceuticals, Inc.?

Morphoceuticals, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Morphoceuticals, Inc. worth (valuation)?

Valuation information for Morphoceuticals, Inc. is not publicly available.

Can I buy Morphoceuticals, Inc. stock?

Morphoceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Morphoceuticals, Inc.'s last funding round?

Morphoceuticals, Inc.'s most recent funding round was Seed on February 15, 2023.

Who are the main investors in Morphoceuticals, Inc.?

Key investors in Morphoceuticals, Inc. include Prime Movers Lab.

Will Morphoceuticals, Inc. IPO soon?

No public IPO plans have been announced for Morphoceuticals, Inc..

How can I track Morphoceuticals, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Morphoceuticals, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMedford, Massachusetts
Employee Range6
Year Founded2020
Last FundingFeb 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?